Nyt fra tidsskrifterne
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Klik på knappen for at kopiere eller tryk på linket nedenfor.
Kopieret til udklipsholder!
Ingen søgeord valgt.
26 emner vises.
Hilary Humphreys, Margreet Vos, Elisabeth Presterl, Markus Hell
Clinical Microbiology and Infection, 12.05.2023
Tilføjet 12.05.2023
Acute care hospitals traditionally have a combination of mixed occupancy rooms, i.e. two or more patients sharing the same room with an ensuite, and single rooms occupied by one patient with or without a lobby. This has been changing in recent years with a move towards single rooms for most if not all patients. Single rooms are currently prioritized for providing a protective environment for immunocompromised patients who are at particular risk of serious infection (protective isolation) or for the isolation of those patients with transmissible infections who pose a risk to other patients (source isolation).
Læs mere Tjek på PubMedAndrea N. Utzon, Isik S. Johansen, Line L. Bang, Rune M. Pedersen, Thomas E. Andersen, Lone W. Madsen
Clinical Microbiology and Infection, 12.05.2023
Tilføjet 12.05.2023
Immunocompromised patients infected with SARS-CoV-2 have been shown to shed replicable virus for a prolonged period of time, and the duration of isolation can therefore be difficult to estimate. The objective of this study was to evaluate the viral load dynamic in non-hospitalized immunocompromised patients infected with SARS-CoV-2 and treated with monoclonal antibodies or antivirals.
Læs mere Tjek på PubMedCarlos Solano de la Asunción, Rafael Hernani, Eliseo Albert, María Dolores Gómez, Estela Giménez, Ana Benzaquén, Eva María González-Barberá, Juan Carlos Hernández-Boluda, Ariadna Pérez, José Luis Piñana, Pedro Chorao, Manuel Guerreiro, Juan Montoro, Jaime Sanz, Carlos Solano, David Navarro
Clinical Microbiology and Infection, 12.05.2023
Tilføjet 12.05.2023
Cytomegalovirus (CMV) DNAemia may develop in a large percentage (up to 45%) of CMV-seropositive patients undergoing in CD19 CAR T-cell therapy [1,2] and may contribute to worsen clinical outcomes [1]. Here, by not administering preemptive antiviral therapy (PET) at low plasma CMV DNA loads (
Læs mere Tjek på PubMedMatus Gonzalez, A., Lorca, E., Cabrera, S., Hernandez, A., Zuniga-SM, C., Sola, L., Michea, L., Ferreiro Fuentes, A., Cervantes, L., Madero, M., Teixeira-Pinto, A., Wong, G., Craig, J., Jaure, A.
BMJ Open, 12.05.2023
Tilføjet 12.05.2023
ObjectiveTo describe the experiences of nephrologists on caring for patients undergoing in-centre haemodialysis during the COVID-19 pandemic in Latin America. DesignTwenty-five semistructured interviews were conducted by Zoom videoconference in English and Spanish languages during 2020 until data saturation. Using thematic analysis, we conducted line-by-line coding to inductively identify themes. Setting25 centres across nine countries in Latin America. ParticipantsNephrologists (17 male and 8 female) were purposively sampled to include diverse demographic characteristics and clinical experience. ResultsWe identified five themes: shock and immediate mobilisation for preparedness (overwhelmed and distressed, expanding responsibilities to manage COVID-19 infection and united for workforce resilience); personal vulnerability (being infected with COVID-19 and fear of transmitting COVID-19 to family); infrastructural susceptibility of dialysis units (lacking resources and facilities for quarantine, struggling to prevent cross-contamination, and depletion of personal protective equipment and cleaning supplies); helplessness and moral distress (being forced to ration life-sustaining equipment and care, being concerned about delayed and shortened dialysis sessions, patient hesitancy to attend to dialysis sessions, being grieved by socioeconomic disparities, deterioration of patients with COVID-19, harms of isolation and inability to provide kidney replacement therapy); and fostering innovative delivery of care (expanding use of telehealth, increasing uptake of PD and shifting focus on preventing syndemics). ConclusionNephrologists felt personally and professionally vulnerable and reported feeling helpless and morally distressed because they doubted their capacity to provide safe care for patients undergoing dialysis. Better availability and mobilisation of resources and capacities to adapt models of care, including telehealth and home-based dialysis, are urgently needed.
Læs mere Tjek på PubMedVillarim, P. V. O., Marinho, V. R. D., Abreu, C. A., Moura, A. C. M. A., Silva, T. C. L., Alves, H. P. M., Rego, A. C. M., Medeiros, K. S., Araujo-Filho, I.
BMJ Open, 12.05.2023
Tilføjet 12.05.2023
IntroductionUp to the present time, the laparoscopic approach for colon cancer is considered the gold standard. However, robotic surgery has been appraised in modern medicine. It is essential to evaluate the differences between laparoscopic and robotic surgery, owing to the significant impact they cause in postoperative morbidity and mortality. This article aims to perform a systematic review and meta-analysis of the literature to compare robotic versus laparoscopic colectomies in patients with colon cancer in terms of the incidence of colonic fistulas. Methods and analysisPubMed, Embase, Scopus, Web of Science, Science Direct, Cochrane Central Register of Controlled Trials, CINAHL, LILACS and Clinical trials databases will be searched for randomised clinical trials investigating the incidence of colonic fistulas in patients with colonic cancer, submitted to robotic surgery compared with a laparoscopic approach. No language or publication period restrictions will be imposed. The primary outcome will be the incidence of colonic fistulas in patients with colon cancer in different surgical approaches. The secondary outcomes will be the incidence of infection, sepsis, mortality, length of hospitalisation and malnutrition. Three independent reviewers will select the studies and extract data from the original publications. The risk of bias will be assessed using The Risk of Bias 2 tool, and the evidence’s certainty will be made using the Grading of Recommendations Assessment, Development and Evaluation. Data synthesis will be performed using the Review Manager software (RevMan V.5.2.3). To assess heterogeneity. We will compute the I2 statistics. In addition, a quantitative synthesis will be performed if the included studies are sufficiently homogeneous. Ethics and disseminationThis study will review the published data; thus, it is not necessary to obtain ethical approval. The findings of this systematic review will be published in a peer-reviewed journal. PROSPERO registration numberCRD42021295313.
Læs mere Tjek på PubMedSingleton, D., Ibarz-Pavon, A., Swarthout, T. D., Bonomali, F., Cornick, J., Kalizangoma, A., Ntiza, N., Brown, C., Chipatala, R., Nyangulu, W., Chirombo, J., Kawalazira, G., Chibowa, H., Mwansambo, C., Maleta, K. M., French, N., Heyderman, R. S.
BMJ Open, 12.05.2023
Tilføjet 12.05.2023
IntroductionVaccination is a potentially critical component of efforts to arrest development and dissemination of antimicrobial resistance (AMR), though little is known about vaccination impact within low-income and middle-income countries. This study will evaluate the impact of vaccination on reducing carriage prevalence of resistant Streptococcus pneumoniae and extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. We will leverage two large ongoing cluster-randomised vaccine evaluations in Malawi assessing; first, adding a booster dose to the 13-valent pneumococcal conjugate vaccine (PCV13) schedule, and second, introduction of the RTS,S/AS01 malaria vaccine. Methods and analysisSix cross-sectional surveys will be implemented within primary healthcare centres (n=3000 users of outpatient facilities per survey) and their local communities (n=700 healthy children per survey): three surveys in Blantyre district (PCV13 component) and three surveys in Mangochi district (RTS,S/AS01 component). We will evaluate antibiotic prescription practices and AMR carriage in children ≤3 years. For the PCV13 component, surveys will be conducted 9, 18 and 33 months following a 3+0 to 2+1 schedule change. For the RTS,S/AS01 component, surveys will be conducted 32, 44 and 56 months post-RTS,S/AS01 introduction. Six health centres in each study component will be randomly selected for study inclusion. Between intervention arms, the primary outcome will be the difference in penicillin non-susceptibility prevalence among S. pneumoniae nasopharyngeal carriage isolates in healthy children. The study is powered to detect an absolute change of 13 percentage points (ie, 35% vs 22% penicillin non-susceptibility). Ethics and disseminationThis study has been approved by the Kamuzu University of Health Sciences (Ref: P01-21-3249), University College London (Ref: 18331/002) and University of Liverpool (Ref: 9908) Research Ethics Committees. Parental/caregiver verbal or written informed consent will be obtained prior to inclusion or recruitment in the health centre-based and community-based activities, respectively. Results will be disseminated via the Malawi Ministry of Health, WHO, peer-reviewed publications and conference presentations.
Læs mere Tjek på PubMedJie Tu, Tianbao Zhu, Qingwen Wang, Wanzhen Yang, Yahui Huang, Defeng Xu, Na Liu, Chunquan Sheng
Emerg Microbes Infect, 12.05.2023
Tilføjet 12.05.2023
Yan Zeng, Xiaoke Liu, Yuwei Li, Jia Lu, Qin Wu, Demiao Dan, Shiyun Lv, Fei Xia, Chunxia Hu, Jiali Li, Hao Zhang, Hongqiao Du, Rui Jia, Kai Duan, Zejun Wang, Xinguo Li, Xiaoming Yang
Emerg Microbes Infect, 12.05.2023
Tilføjet 12.05.2023
Fengbin Wang, Lisa Craig, Xing Liu, Christopher Rensing, Edward H. Egelman
Trends in Microbiology, 12.05.2023
Tilføjet 12.05.2023
A few non-scientific statements were removed and/or edited. These corrections have been updated in the current online version of the article. The editor regrets any inconvenience caused.
Læs mere Tjek på PubMedThe Lancet
Lancet, 12.05.2023
Tilføjet 12.05.2023
In early 2020, as part of a worldwide campaign to raise the profile of nursing, WHO, the International Council of Nurses (ICN), and Nursing Now published the first State of the World\'s Nursing report, setting out a global strategy for nursing. At the time, we highlighted how the report could inform policy dialogues and promote recognition of the potential of nursing to enable universal health coverage, and emphasised how crucial the subsequent years would be to show the impact of nursing. The COVID-19 pandemic has proven just how important these messages were.
Læs mere Tjek på PubMedSant-Rayn Pasricha, Martin N Mwangi, Ernest Moya, Ricardo Ataide, Glory Mzembe, Rebecca Harding, Truwah Zinenani, Leila M Larson, Ayse Y Demir, William Nkhono, Jobiba Chinkhumba, Julie A Simpson, Danielle Clucas, William Stones, Sabine Braat, Kamija S Phiri
Lancet, 12.05.2023
Tilføjet 12.05.2023
In this malaria-endemic sub-Saharan African setting, treatment of anaemic pregnant women with ferric carboxymaltose was safe but did not reduce anaemia prevalence at 36 weeks\' gestation or increase birthweight.
Læs mere Tjek på PubMedJeremy Zeggagh, Olivier Ferraris, Maud Salmona, Arnaud Tarantola, Jean-Michel Molina, Constance Delaugerre
Lancet, 12.05.2023
Tilføjet 12.05.2023
A 36-year-old man attended our hospital with an 8-day history of two vesiculopustular lesions on his penis (figure); he reported no fever or inguinal lymphadenopathy. The patient had no previous history of note; he had not been immunised against smallpox. Over the past 3 years he said that he regularly took pre-exposure prophylaxis (PrEP) against HIV.
Læs mere Tjek på PubMedAdan Chari Jirmo, Ruth Grychtol, Svenja Gaedcke, Bin Liu, Stephanie DeStefano, Christine Happle, Olga Halle, Joao T. Monteiro, Anika Habener, Oliver D. Breiholz, David DeLuca, Gesine Hansen
Frontiers in Immunology, 12.05.2023
Tilføjet 12.05.2023
A single population of interferon-regulatory factor 8 (Irf8)-dependent conventional dendritic cell (cDC type1) is considered to be responsible for both immunogenic and tolerogenic responses depending on the surrounding cytokine milieu. Here, we challenge this concept of an omnipotent single Irf8-dependent cDC1 cluster through analysis of pulmonary cDCs at single cell resolution. We report existence of a pulmonary cDC1 cluster lacking Xcr1 with an immunogenic signature that clearly differs from the Xcr1 positive cDC1 cluster. The Irf8+Batf3+Xcr1- cluster expresses high levels of pro-inflammatory genes associated with antigen presentation, migration and co-stimulation such as Ccr7, Cd74, MHC-II, Ccl5, Il12b and Relb while, the Xcr1+ cDC1 cluster expresses genes corresponding to immune tolerance mechanisms like Clec9a, Pbx1, Cadm1, Btla and Clec12a. In concordance with their pro-inflammatory gene expression profile, the ratio of Xcr1- cDC1s but not Xcr1+cDC1 is increased in the lungs of allergen-treated mice compared to the control group, in which both cDC1 clusters are present in comparable ratios. The existence of two distinct Xcr1+ and Xcr1- cDC1 clusters is furthermore supported by velocity analysis showing markedly different temporal patterns of Xcr1- and Xcr1+cDC1s. In summary, we present evidence for the existence of two different cDC1 clusters with distinct immunogenic profiles in vivo. Our findings have important implications for DC-targeting immunomodulatory therapies.
Læs mere Tjek på PubMedDavid S Hui, Louise Yung, Ken KP Chan, Susanna S Ng, Grace Lui, Fanny W Ko, Tat-On Chan, Karen Yiu, Yuguo Li, Matthew TV Chan, Hui-Ling Yen
International Journal of Infectious Diseases, 12.05.2023
Tilføjet 12.05.2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of Coronavirus disease 2019 (COVID-19) [1, 2]. Patients with severe COVID-19 infection often progress to acute hypoxemic respiratory failure (AHRF) requiring high concentration of inspired oxygen (FiO2) and consideration for non-invasive ventilation (NIV) strategies [3-5]. High-flow nasal cannula (HFNC) has emerged as a non-invasive strategy to improve oxygenation and clearance of carbon dioxide [6, 7].
Læs mere Tjek på PubMedFEMS Microbiology Reviews, 12.05.2023
Tilføjet 12.05.2023
AbstractIt is almost a century since nisin was discovered in fermented milk cultures, coincidentally in the same year that penicillin was first described. Over the last 100 years this small, highly modified pentacyclic peptide has not only found success in the food industry as a preservative but has also served as the paradigm for our understanding of the genetic organization, expression and regulation of genes involved in lantibiotic biosynthesis – one of the few cases of extensive post-translation modification in prokaryotes. Recent developments in understanding the complex biosynthesis of nisin have shed light on the cellular location of the modification and transport machinery and the co-ordinated series of spatio-temporal events required to produce active nisin and provide resistance and immunity. The continued unearthing of new natural variants from within human and animal gastrointestinal tracts has sparked interest in the potential application of nisin to influence the microbiome, given the growing recognition of the role the gastrointestinal microbiota plays in health and disease. Moreover, interdisciplinary approaches have taken advantage of biotechnological advancements to bioengineer nisin to produce novel variants and expand nisin functionality for applications in the biomedical field. This review will discuss the latest progress in these aspects of nisin research.
Læs mere Tjek på PubMedBMC Infectious Diseases, 12.05.2023
Tilføjet 12.05.2023
Abstract Introduction The HIV Prevention Trials Network (HPTN) 074 study demonstrated a positive effect of an integrated systems navigation and psychosocial counseling intervention on HIV treatment initiation, viral suppression, medication assisted treatment (MAT) enrollment, and risk of death among people who inject drugs (PWID). In this sub-study, we analyzed the incidence, causes, and predictors of death among HIV-infected and uninfected participants. Methods The HPTN 074 randomized clinical trial was conducted in Indonesia, Ukraine, and Vietnam. HIV-infected PWID with unsuppressed viral load (indexes) were recruited together with at least one of their HIV-negative injection partners. Indexes were randomized in a 1:3 ratio to the intervention or standard of care. Results The trial enrolled 502 index and 806 partner participants. Overall, 13% (66/502) of indexes and 3% (19/806) of partners died during follow-up (crude mortality rates 10.4 [95% CI 8.1–13.3] and 2.1 [1.3–3.3], respectively). These mortality rates were for indexes nearly 30 times and for partners 6 times higher than expected in a population of the same country, age, and gender (standardized mortality ratios 30.7 [23.7–39.0] and 5.8 [3.5–9.1], respectively). HIV-related causes, including a recent CD4
Læs mere Tjek på PubMedBMC Infectious Diseases, 12.05.2023
Tilføjet 12.05.2023
Abstract Background Vaccination is a key tool against COVID-19. However, in many settings it is not clear how acceptable COVID-19 vaccination is among the general population, or how hesitancy correlates with risk of disease acquisition. In this study we conducted a nationally representative survey in Pakistan to measure vaccination perceptions and social contacts in the context of COVID-19 control measures and vaccination programmes. Methods We conducted a vaccine perception and social contact survey with 3,658 respondents across five provinces in Pakistan, between 31 May and 29 June 2021. Respondents were asked a series of vaccine perceptions questions, to report all direct physical and non-physical contacts made the previous day, and a number of other questions regarding the social and economic impact of COVID-19 and control measures. We examined variation in perceptions and contact patterns by geographic and demographic factors. We describe knowledge, experiences and perceived risks of COVID-19. We explored variation in contact patterns by individual characteristics and vaccine hesitancy, and compared to patterns from non-pandemic periods. Results Self-reported adherence to self-isolation guidelines was poor, and 51% of respondents did not know where to access a COVID-19 test. Although 48.1% of participants agreed that they would get a vaccine if offered, vaccine hesitancy was higher than in previous surveys, and greatest in Sindh and Baluchistan provinces and among respondents of lower socioeconomic status. Participants reported a median of 5 contacts the previous day (IQR: 3–5, mean 14.0, 95%CI: 13.2, 14.9). There were no substantial differences in the number of contacts reported by individual characteristics, but contacts varied substantially among respondents reporting more or less vaccine hesitancy. Contacts were highly assortative, particularly outside the household where 97% of men\'s contacts were with other men. We estimate that social contacts were 9% lower than before the COVID-19 pandemic. Conclusions Although the perceived risk of COVID-19 in Pakistan is low in the general population, around half of participants in this survey indicated they would get vaccinated if offered. Vaccine impact studies which do not account for correlation between social contacts and vaccine hesitancy may incorrectly estimate the impact of vaccines, for example, if unvaccinated people have more contacts.
Læs mere Tjek på PubMedBMC Infectious Diseases, 12.05.2023
Tilføjet 12.05.2023
Abstract Background Numerous vaccination research experiments have been conducted on non-primate hosts to prevent or control HTLV-1 infection. Therefore, reviewing recent advancements for status assessment and strategic planning of future preventative actions to reduce HTLV-1 infection and its consequences would be essential. Methods MEDLINE, Scopus, Web of Science, and Clinicaltrials.gov were searched from each database\'s inception through March 27, 2022. All original articles focusing on developing an HTLV-1 vaccine candidate were included. Results A total of 47 studies were included. They used a variety of approaches to develop the HTLV-1 vaccine, including DNA-based, dendritic-cell-based, peptide/protein-based, and recombinant vaccinia virus approaches. The majority of the research that was included utilized Tax, Glycoprotein (GP), GAG, POL, REX, and HBZ as their main peptides in order to develop the vaccine. The immunization used in dendritic cell-based investigations, which were more recently published, was accomplished by an activated CD-8 T-cell response. Although there hasn\'t been much attention lately on this form of the vaccine, the initial attempts to develop an HTLV-1 immunization depended on recombinant vaccinia virus, and the majority of results seem positive and effective for this type of vaccine. Few studies were conducted on humans. Most of the studies were experimental studies using animal models. Adenovirus, Cytomegalovirus (CMV), vaccinia, baculovirus, hepatitis B, measles, and pox were the most commonly used vectors. Conclusions This systematic review reported recent progression in the development of HTLV-1 vaccines to identify candidates with the most promising preventive and therapeutic effects.
Læs mere Tjek på PubMedBMC Infectious Diseases, 12.05.2023
Tilføjet 12.05.2023
Abstract Background HIV disclosure is vital in HIV management. Community Health Workers (CHW) were reported to support partner disclosure among HIV affected heterosexual partners with disclosure difficulties. However, time to disclosure attributed to use of CHW led disclosure support mechanism was not documented. This study compared the incidence of sexual partner disclosure among adults living with HIV (ALHIV) with CHW support and those without in the greater Luwero region, Uganda. Methods We conducted a quasi-experimental study with two arms allocated by geographically determined clusters and adjusted for between-group differences; among ALHIV in the greater Luwero region of Uganda who had never disclosed to their current primary sexual partners. We allocated study clusters to either a CHW-led intervention or control arm. In both arms, we consecutively recruited participants; those in the intervention arm received CHW disclosure support in addition to routine care. The overall follow-up was six months, and the primary outcome was disclosure to the partner. We used survival analysis with proportional hazard ratios to determine the time to partner disclosure in both arms. Results A total of 245 participants were enrolled, and 230 (93.9%) completed the study; of these, 112 (48.7%) were in the intervention and 118 (51.3%) in the control arm. The mean age was 31 ± 8 years with a range of 18 to 55 years; the majority were females, 176 (76.5%). The cumulative incidence of disclosure was higher in the intervention arm, 8.76 [95% CI: 7.20–10.67] per 1,000 person-days versus 5.15 [95%CI: 4.85–6.48] per 1,000 person-days in the control arm, log-rank test, X2 = 12.93, P six months, aHR = 1.19 predicted disclosure. Prior disclosure to a relative, aHR = 0.55, and having more than one sexual partner in the past three months, aHR = 0.74, predicted non-disclosure. Conclusion CHW-led support mechanism increased the rate of sexual partner disclosure among ALHIV with disclosure difficulties. Therefore, to achieve the global targets of ending HIV, near location CHW-led disclosure support mechanism may be used to hasten HIV disclosure in rural settings.
Læs mere Tjek på PubMedKeith S Kaye, Andrew F Shorr, Richard G Wunderink, Bin Du, Gabrielle E Poirier, Khurram Rana, Alita Miller, Drew Lewis, John O'Donnell, Lan Chen, Harald Reinhart, Subasree Srinivasan, Robin Isaacs, David Altarac
Lancet Infectious Diseases, 12.05.2023
Tilføjet 12.05.2023
Our data show that sulbactam–durlobactam was non-inferior to colistin, both agents given in combination with imipenem–cilastatin, for the primary endpoint of 28-day all-cause mortality. Sulbactam–durlobactam was well tolerated and could be an effective intervention to reduce mortality from serious infections caused by carbapenem-resistant ABC, including multidrug-resistant strains.
Læs mere Tjek på PubMedMartin Klapper, Alexander Hübner, Anan Ibrahim, Ina Wasmuth, Maxime Borry, Veit G. Haensch, Shuaibing Zhang, Walid K. Al-Jammal, Harikumar Suma, James A. Fellows Yates, Jasmin Frangenberg, Irina M. Velsko, Somak Chowdhury, Rosa Herbst, Evgeni V. Bratovanov, Hans-Martin Dahse, Therese Horch, Christian Hertweck, Manuel Ramon González Morales, Lawrence Guy Straus, Ivan Vilotijevic, Christina Warinner, Pierre Stallforth
Science, 11.05.2023
Tilføjet 11.05.2023
Kai Kupferschmidt and Meredith Wadman
Science, 11.05.2023
Tilføjet 11.05.2023
Jeshina JanardhananChoon KimYuanyuan QianJingdong YangJayda E. MeiselDerong DingEnrico SperiValerie A. SchroederWilliam R. WolterAllen G. OliverShahriar MobasheryMayland ChangaDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556bFreimann Life Sciences Center, University of Notre Dame, Notre Dame, IN 46556
Proceedings of the National Academy of Sciences, 11.05.2023
Tilføjet 11.05.2023
Proceedings of the National Academy of Sciences, Volume 120, Issue 20, May 2023.
Læs mere Tjek på PubMedBenjamin S. GoldbergDavid A. SpencerShilpi PandeyTracy OrdonezPhilip BarnetteYun YuLina GaoJérémy DuflooTimothée BruelOlivier SchwartzMargaret E. AckermanAnn J. HessellaThayer School of Engineering, Dartmouth College, Hanover, NH 03755bDivision of Pathobiology and Immunology, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006cBiostatistics Shared Resources, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239dBiostatistics & Bioinformatics Core, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006eInstitut Pasteur, Université de Paris, CNRS UMR3569, Virus and Immunity Unit, 75015 Paris, FrancefUniversité de Paris, École doctorale BioSPC 562, 75013 Paris, FrancegVaccine Research Institute, 94000 Créteil, FrancehDepartment of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755
Proceedings of the National Academy of Sciences, 11.05.2023
Tilføjet 11.05.2023
Proceedings of the National Academy of Sciences, Volume 120, Issue 20, May 2023.
Læs mere Tjek på PubMedGiovanna CapovillaRogier BraakmanGregory P. FournierThomas HacklJulia SchwartzmanXinda LuAlexis YeltonKrista LongneckerMelissa C. Kido SouleElaina ThomasGretchen SwarrAlessandro MongeraJack G. PayetteKurt G. CastroJacob R. WaldbauerElizabeth B. KujawinskiOtto X. CorderoSallie W. ChisholmaDepartment of Civil and Environmental Engineering, Massachusetts Institute of Technology, 02139 Cambridge, MAbDepartment of Earth, Atmospheric, and Planetary Sciences, Massachusetts Institute of Technology, 02139 Cambridge, MAcGroningen Institute of Evolutionary Life Sciences, University of Groningen, 9747 Groningen, NetherlandsdDepartment of Marine Chemistry and Geochemistry, Woods Hole Oceanographic Institution, 02543 Woods Hole, MAeDepartment of Pathology, Brigham and Women’s Hospital, 02115 Boston, MAfDepartment of Genetics, Harvard Medical School, 02115 Boston, MAgDepartment of the Geophysical Sciences, University of Chicago, 60637 Chicago, ILhDepartment of Biology, Massachusetts Institute of Technology, 02139 Cambridge, MA
Proceedings of the National Academy of Sciences, 11.05.2023
Tilføjet 11.05.2023
Proceedings of the National Academy of Sciences, Volume 120, Issue 20, May 2023.
Læs mere Tjek på PubMedIan J. RoneyDavid Z. RudneraDepartment of Microbiology, Harvard Medical School, Boston, MA 02115
Proceedings of the National Academy of Sciences, 11.05.2023
Tilføjet 11.05.2023
Proceedings of the National Academy of Sciences, Volume 120, Issue 20, May 2023.
Læs mere Tjek på PubMed